Healthia Management

Management Kriterienprüfungen 3/4

Healthia CEO ist Wes Coote , ernannt in Apr 2019, hat eine Amtszeit von 4.67 Jahren. Die jährliche Gesamtvergütung beträgt A$660.60K , bestehend aus 60.2% Gehalt und 39.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.42% der Aktien des Unternehmens, im Wert von A$3.58M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 1.4 Jahre bzw. 5.6 Jahre.

Wichtige Informationen

Wes Coote

Geschäftsführender

AU$660.6k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts60.2%
Amtszeit als Geschäftsführer4.7yrs
Eigentum des Geschäftsführers1.4%
Durchschnittliche Amtszeit des Managements1.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.6yrs

Jüngste Management Updates

Recent updates

Calculating The Fair Value Of Healthia Limited (ASX:HLA)

Jan 30
Calculating The Fair Value Of Healthia Limited (ASX:HLA)

Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02

Mar 02
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02

Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise

Nov 09
Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise

Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%

Sep 17
Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%

Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Sep 17
Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

Sep 01
Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025

I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Aug 17
I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease

Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

May 19
Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?

Is Healthia (ASX:HLA) A Risky Investment?

Apr 19
Is Healthia (ASX:HLA) A Risky Investment?

With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Apr 03
With EPS Growth And More, Healthia (ASX:HLA) Is Interesting

Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Mar 19
Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year

Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

Mar 06
Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares

What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Feb 26
What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?

Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Feb 09
Is There Now An Opportunity In Healthia Limited (ASX:HLA)?

Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 19
Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Why Dividend Hunters Love Healthia Limited (ASX:HLA)

Dec 29
Why Dividend Hunters Love Healthia Limited (ASX:HLA)

Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?

Dec 10
Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?

We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings

Nov 20
We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Wes Coote im Vergleich zu den Einnahmen von Healthia verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 30 2023AU$661kAU$398k

AU$5m

Mar 31 2023n/an/a

AU$3m

Dec 31 2022n/an/a

AU$781k

Sep 30 2022n/an/a

-AU$1m

Jun 30 2022AU$516kAU$345k

-AU$3m

Mar 31 2022n/an/a

-AU$2m

Dec 31 2021n/an/a

AU$161k

Sep 30 2021n/an/a

AU$3m

Jun 30 2021AU$400kAU$306k

AU$5m

Mar 31 2021n/an/a

AU$6m

Dec 31 2020n/an/a

AU$7m

Sep 30 2020n/an/a

AU$5m

Jun 30 2020AU$313kAU$225k

AU$3m

Mar 31 2020n/an/a

AU$1m

Dec 31 2019n/an/a

AU$271k

Sep 30 2019n/an/a

-AU$483k

Jun 30 2019AU$226kAU$176k

-AU$1m

Vergütung im Vergleich zum Markt: WesDie Gesamtvergütung ($USD439.78K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Australian ($USD708.27K).

Entschädigung vs. Einkommen: WesDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Wes Coote

4.7yrs

Amtszeit

AU$660,599

Vergütung

Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Wesley Coote
Group MD4.7yrsAU$660.60k1.42%
A$ 3.6m
Damien Peters
Group Chief Financial Officerless than a yearAU$319.83kkeine Daten
Darren Stewart
Director of Podiatry & Executive Directorno dataAU$115.34k6.4%
A$ 16.1m
Lisa Roach
Group Chief Partnerships Officer & Executive Directorless than a yearAU$391.84k0.75%
A$ 1.9m
Colin Kangisser
CEO of Eyes & Ears Division and Director2.7yrsAU$368.92k3.66%
A$ 9.2m
Roy Walker
Chief Executive Officer of Bodiesless than a yearAU$314.24kkeine Daten
Dean Hartley
Chief Technology Officer1.9yrsAU$261.49k2.49%
A$ 6.3m
Julia Murfitt
General Counsel & Company Secretary1.8yrskeine Datenkeine Daten
Anthony Ganter
Group Chief Business Development & Strategy Officerno dataAU$341.32k0%
A$ 0
Kerrie Evans
Group Chief Education & Research Officerno datakeine Datenkeine Daten
Aaron Kangisser
Chief Operating Officer of Eyes & Ears Divisionless than a yearkeine Datenkeine Daten

1.4yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrenes Management: HLADas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.4 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Wesley Coote
Group MD4.7yrsAU$660.60k1.42%
A$ 3.6m
Darren Stewart
Director of Podiatry & Executive Director5.6yrsAU$115.34k6.4%
A$ 16.1m
Lisa Roach
Group Chief Partnerships Officer & Executive Director1.7yrsAU$391.84k0.75%
A$ 1.9m
Colin Kangisser
CEO of Eyes & Ears Division and Director2.7yrsAU$368.92k3.66%
A$ 9.2m
Glen Richards
Non-Executive Chairman5.6yrsAU$130.00k5.67%
A$ 14.3m
Paul Wilson
Independent Non-Executive Director5.6yrsAU$80.00k2.51%
A$ 6.3m
Lisa Dalton
Independent Non-Executive Director5.6yrsAU$80.00k0.034%
A$ 85.2k

5.6yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: HLADie Vorstandsmitglieder gelten als erfahren (5.6 Jahre durchschnittliche Amtszeit).